Indefinite Delivery Contract SPE2DX15D1206
- Not listed
- The federal contract IDV award SPE2DX15D6042 is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at up to $4,999,999.00, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and runs through December 31, 2025. Under this IDC, Amerisourcebergen Drug Corp provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- The federal contract IDV award SPE2DX15D6043 is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at up to $4,999,999.00, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and runs through December 31, 2025. Under this IDC, Amerisourcebergen Drug Corp serves as the primary vendor for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
- The federal contract IDV award SPE2DX16D9940 is an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has a ceiling value of $4,999,999.99 with a period of performance through December 31, 2025. Under this single-award IDC, Amerisourcebergen Drug Corp serves as the prime contractor providing a comprehensive range of...
- The federal contract IDV award SPE2DX16D3910 is an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $4,999,999.00 and runs through November 23, 2023. The contract aims to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty...
- The federal contract IDV award, SPE2DX16D9947, is an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This single-award IDC was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, with a ceiling value of $4,999,999.99 and a period of performance through December 25, 2025. Under this IDC, Amerisourcebergen Drug Corp serves as the prime contractor responsible for providing a comprehensive...
- The federal contract IDV award SPE2DX15D5013 is an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical with a total ceiling value of $4,999,999.00 and a period of performance through December 31, 2025. Under this IDC, Amerisourcebergen Drug Corp serves as the prime contractor responsible for providing a comprehensive range of pharmaceutical products and medical...
- The federal contract IDV award SPE2DX16D2918 is an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, has a ceiling value of $4,999,999.99 and runs through December 31, 2025. Under this IDC, Amerisourcebergen Drug Corp serves as a prime vendor, delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- The federal contract IDV award SPE2DX15D1042 is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $4,999,999.00 contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on April 10, 2015, with a performance period through December 31, 2025. Under this IDC, Amerisourcebergen Drug Corp serves as the prime vendor responsible for delivering a comprehensive range of pharmaceutical...
- The federal contract IDV award SPE2DX16D3901 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,999,999.00 IDC, with a period of performance through November 23, 2023, is designed to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses a broad spectrum of...
- The federal contract IDV award SPE2DX16D3925 is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and subsidiary of Cencora, Inc. The $4,999,999.00 contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC serves as the primary vehicle for...
The federal contract IDV award SPE2DX15D1206 is an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a ceiling value of $4,999,999.00, with a period of performance through December 31, 2025. Under this IDC, Amerisourcebergen Drug Corp serves as the prime contractor responsible for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contracted items include specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across various therapeutic areas such as cardiovascular health, diabetes management, mental health, pain management, infectious disease prevention, and general medical care. This IDC enables the DLA to efficiently procure essential pharmaceutical and medical commodities to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined contracting mechanism. The contract was awarded through full and open competition without any set-aside requirements, reflecting Amerisourcebergen's strong position in the pharmaceutical distribution market.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 4/12/15 |